Why I Like AVUV, AVDV, and AVGV: Turning Factor Research into a Portfolio

From Research to Portfolio

The previous guide made the case for small-cap value as a factor tilt: decades of evidence, a plausible economic story, and enough discomfort to keep the premium alive. This guide is about implementation. How do you actually own it?

I like AVUV, AVDV, and AVGV because they are practical, disciplined vehicles for targeting the parts of the equity market that academic research has long associated with higher expected returns: smaller companies, lower relative valuations, and higher profitability. They are not guaranteed winners. They can lag badly for years. But they are diversified, rules-informed, and rooted in a body of research that is stronger than most investing narratives.

This guide also covers DFSV, DISV, and DGEIX as Dimensional alternatives for investors who prefer that platform.

This is educational content, not investment advice. Verify all fund details against the latest prospectus before making investment decisions.

What Ties These Funds Together

What I like is not just "small-cap value" in the abstract but small-cap value with disciplined implementation. Avantis describes its ETFs as strategies that seek the benefits of indexing (diversification, low turnover, transparency) while still using current prices to make investment decisions. Dimensional says its systematic equity process emphasizes smaller cap, lower relative price, and higher profitability stocks with flexible implementation to manage trading costs.

You are not buying a story stock or a style label. You are buying a repeatable process that turns the academic case for size, value, and profitability into diversified, rules-informed portfolios. Avantis' scientific approach paper describes this philosophy in detail: using financial science to design portfolios that target higher expected returns while managing real-world implementation costs.

Fund-by-Fund Breakdown

AVUV: U.S. Small-Cap Value

AVUV is the cleanest expression of a U.S. small-value tilt. Avantis describes it as a strategy designed to increase expected returns by investing in U.S. small-cap companies trading at low valuations and with higher profitability ratios. It is actively managed, not an index tracker, which gives it flexibility in portfolio construction and rebalancing.

Why I like it: AVUV provides a meaningful small-value tilt instead of a diluted "broad market plus a hint of value" product. The profitability screen addresses the "junk" problem (avoiding the worst balance sheets and most speculative micro-caps) that AQR's research identified as a weakness of raw small-cap strategies.

AVDV: International Small-Cap Value

AVDV is the non-U.S. developed-markets counterpart to AVUV. Avantis describes it as designed to increase expected returns by investing in non-U.S. developed small-cap companies trading at low valuations and with higher profitability ratios.

Why I like it: AVDV lets you extend the same factor logic internationally rather than making your small-value conviction a U.S.-only bet. If you believe in the case for global diversification, then your factor tilts should also be global. The Fama-French international evidence shows value premiums are larger for small stocks in nearly every region except Japan.

AVGV: One-Ticket Global Value

AVGV is different. It is a fund-of-funds that provides a global value allocation across U.S., international developed, and emerging markets. It holds other Avantis funds underneath.

Why I like it: AVGV is for investors who want a global value sleeve without manually combining and rebalancing several regional funds. One ticker, global exposure, value tilt. The tradeoff: you accept Avantis' asset-allocation and weighting decisions on top of the underlying stock selection. At 0.26%, the cost is reasonable for the convenience.

The Dimensional Alternatives: DFSV, DISV, DGEIX

DFSV and DISV are Dimensional's ETF equivalents to AVUV and AVDV. Dimensional systematically overweights smaller cap, lower relative price, and higher profitability stocks with flexible implementation to manage trading costs.

The distinction between AVUV and DFSV is not that one is "right" and the other "wrong." Both are attempts to turn the same research into practice, with somewhat different portfolio-construction choices and fee levels. AVUV is slightly cheaper (0.25% vs. ~0.31%). DFSV has Dimensional's longer institutional track record behind the strategy (even though the ETF wrapper is newer).

DGEIX is the outlier. It is a global equity mutual fund, not a targeted small-value ETF. Dimensional describes it as a broader equity solution with factor-aware implementation. Think of it as a global equity anchor that tilts toward size, value, and profitability, not a pure factor bet. It is for investors who want the Dimensional worldview without concentrating all exposure in small value.

Who These Funds Are For

• Long time horizon (10+ years). The size and value premiums are expected but volatile. Dimensional's research shows realized premiums can be negative over rolling multi-year periods. You need time for the odds to work in your favor.
• Willingness to deviate from the S&P 500. These funds will not track the S&P 500. When large-cap growth dominates (as it did 2010-2024), these funds underperform, and the tracking error feels like a mistake. It is not.
• Belief in the factor evidence. If you have read the research (Fama-French, AQR, Dimensional) and find the case for size, value, and profitability compelling, these funds are practical implementations. If you have not, start with the small-cap value guide first.
• Already owning broad market exposure. These funds are tilts, not replacements. They work best alongside total market funds like VTI and VXUS, not as standalone holdings.

Who These Funds Are NOT For

• Investors who need their portfolio to match the S&P 500 every quarter. Dimensional explicitly warns that value investing can underperform other equity strategies, and realized premiums can be negative for years.
• Short time horizons. If you need the money in 3-5 years, factor tilts add volatility without enough time for the expected premium to materialize.
• Investors who want the lowest possible fee. AVUV at 0.25% and DISV at 0.42% are reasonable for targeted systematic strategies, but they are above ultra-cheap index ETFs like VTI (0.03%) or VXUS (0.07%). The premium in fees is the cost of the factor tilt.
• Investors who will panic and sell during underperformance. The premium exists because it is painful. If you sell after 3 years of lagging the S&P 500, you realize the pain without the premium. That is the worst possible outcome.

How I Think About Allocation

A common approach is to use these as 10-30% overweights within a globally diversified portfolio. For example:

This is an illustrative example, not a recommendation. Your allocation should reflect your own risk tolerance, time horizon, and tax situation.

The core holdings (VTI + VXUS) ensure you participate in whatever the broad market does. The tilts (AVUV + AVDV + AVGV) add exposure to the factors you believe in. If the tilts underperform for a decade, the core keeps you whole. If the tilts outperform, they boost returns meaningfully. That is the structure of a portfolio that does not depend on any single outcome.

You can see your portfolio's actual factor loadings in Summitward's portfolio analysis. The Carhart 4-factor regression shows your SMB (size), HML (value), and MOM (momentum) exposures, so you can verify whether your factor tilt is as strong as you intended.

Frequently Asked Questions

What is the difference between AVUV and DFSV?

Both target U.S. small-cap value stocks with profitability screens. AVUV is managed by Avantis (American Century) with a 0.25% expense ratio. DFSV is managed by Dimensional with a ~0.31% expense ratio. The portfolios differ in construction details but share the same factor philosophy. Neither is objectively "better"; they are different implementations of the same research.

Is AVGV a replacement for VTI + VXUS?

No. AVGV is a global value allocation, not a total market fund. It tilts heavily toward value stocks and away from growth. If you use AVGV as your only equity holding, you would have minimal exposure to growth companies. It works best as a complement to broad market holdings, not a replacement.

Why are these funds more expensive than VTI?

VTI (0.03%) tracks a cap-weighted index with minimal decision-making. AVUV (0.25%) and DFSV (~0.31%) actively screen for value and profitability, which requires research, portfolio construction, and more frequent trading. The higher fee pays for the factor tilt. Whether the tilt is worth the fee depends on your belief in the factor evidence and your time horizon.

Can these funds underperform the S&P 500 for a decade?

Yes. From 2010 to 2024, U.S. large-cap growth dominated and small-cap value significantly underperformed. Dimensional's research confirms that realized premiums can be negative over rolling multi-year periods. The premium is expected, not guaranteed on any investor's schedule.

Should I put my entire portfolio in these funds?

No. These are factor tilts, not core holdings. Concentrating entirely in small-cap value maximizes tracking error and drawdown risk. A more robust approach is 60-70% in broad market funds (VTI, VXUS) with 30-40% in targeted factor tilts (AVUV, AVDV, AVGV).

Key Takeaways

• AVUV, AVDV, and AVGV turn factor research into portfolios. They target smaller, cheaper, more profitable companies through diversified, rules-informed processes.
• DFSV, DISV, and DGEIX are Dimensional alternatives with the same factor philosophy and slightly different implementation and fee structures.
• These are tilts, not replacements. They work best alongside broad market holdings (VTI + VXUS), not as standalone portfolios.
• The "who this is NOT for" list matters. Short time horizons, low tracking error tolerance, or inability to hold through multi-year underperformance are genuine disqualifiers.
• Fees are reasonable for what you get. 0.25% to 0.42% is the cost of targeted systematic factor exposure, not commodity beta. Judge the fee against the strategy, not against VTI.
• The premium is not guaranteed. Both Avantis and Dimensional explicitly warn that premiums are volatile and can be negative for years. That honesty is part of why I trust these firms.

Related Guides

• If Dimensional Gets Sold, Should Factor Investors Care? covers fund-sponsor and strategy-drift risk, and the tax cost of switching between bespoke factor ETFs in a taxable account.
• AVGV Review: A One-Ticker Global Value Tilt is the AVGV-specific deep dive with an interactive calculator comparing AVGV to a DIY basket of the six underlying Avantis ETFs.
• RMW Explained: The Profitability Factor — covers how Avantis (cash-based operating profitability + joint value/profitability ranking) and Dimensional (operating profitability) differ on the profitability metric these funds use, and what the RMW evidence actually says.
• The Case for Small-Cap Value — the academic evidence behind the factor premium these funds target
• Fama-French Factor Analysis — the complete SMB, HML, and profitability framework
• The Case for Global Equity Diversification — why AVDV and DISV matter as much as AVUV and DFSV
• Growth Stocks vs. Systematic Momentum — understanding the factor landscape these funds operate in